Upregulation of lncRNA MEG3 promotes osteogenic differentiation of mesenchymal stem cells from multiple myeloma patients by targeting BMP4 transcription

Stem Cells

Volumn 33, Issue 6, 2015, Pages 1985-1997

  Zhuang, Wenzhuo ^a   Ge, Xueping ^a   Yang, Sijun ^a   Huang, Moli ^a   Zhuang, Wenyue ^b   Chen, Ping ^a   Zhang, Xiaohui ^a   Fu, Jinxiang ^a   Qu, Jing ^a   Li, Bingzong ^a  

^a SOOCHOW UNIVERSITY   (China)

^b BEIHUA UNIVERSITY   (China)

Author keywords

Long noncoding RNA; Maternally expressed gene 3; Mesenchymal stem cells; Multiple myeloma; Transcription

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; LONG UNTRANSLATED RNA; MEG3 PROTEIN; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; BMP4 PROTEIN, HUMAN; MEG3 NON-CODING RNA, HUMAN; TRANSCRIPTION FACTOR SOX;

ARTICLE; BONE DEVELOPMENT; CANCER PATIENT; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MULTIPLE MYELOMA; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; UPREGULATION; CYTOLOGY; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY;

BONE MORPHOGENETIC PROTEIN 4; CELL DIFFERENTIATION; HUMANS; MESENCHYMAL STROMAL CELLS; MULTIPLE MYELOMA; OSTEOGENESIS; RNA, LONG NONCODING; SOXB1 TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84929728345     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1989     Document Type: Article

References (46)

1. Raje N, Roodman GD,. Advances in the biology and treatment of bone disease in multiple myeloma. Clin Cancer Res 2011; 17: 1278-1286.
2. Giuliani N, Rizzoli V, Roodman GD,. Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition. Blood 2006; 108: 3992-3996.
3. Arnulf B, Lecourt S, Soulier J, et al., Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma. Leukemia 2007; 21: 158-163.
4. Corre J, Mahtouk K, Attal M, et al., Bone marrow mesenchymal stem cells are abnormal in multiple myeloma. Leukemia 2007; 21: 1079-1088.
5. Garderet L, Mazurier C, Chapel A, et al., Mesenchymal stem cell abnormalities in patients with multiple myeloma. Leukemia Lymphoma 2007; 48: 2032-2041.
6. Garayoa M, Garcia JL, Santamaria C, et al., Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors. Leukemia 2009; 23: 1515-1527.
7. Xu S, Evans H, Buckle C, et al., Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway. Leukemia 2012; 26: 2546-2549.
8. Giuliani N, Colla S, Morandi F, et al., Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation. Blood 2005; 106: 2472-2483.
9. Giuliani N, Rizzoli V,. Myeloma cells and bone marrow osteoblast interactions: Role in the development of osteolytic lesions in multiple myeloma. Leukemia Lymphoma 2007; 48: 2323-2329.
10. Li B, Shi M, Li J, et al., Elevated tumor necrosis factor-alpha suppresses TAZ expression and impairs osteogenic potential of Flk-1+ mesenchymal stem cells in patients with multiple myeloma. Stem Cells Dev 2007; 16: 921-930.
11. Khurana S, Buckley S, Schouteden S, et al., A novel role of BMP4 in adult hematopoietic stem and progenitor cell homing via Smad independent regulation of integrin-alpha4 expression. Blood 2013; 121: 781-790.
12. Koli K, Myllarniemi M, Vuorinen K, et al., Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis. Am J Pathol 2006; 169: 61-71.
13. Rosendahl A, Pardali E, Speletas M, et al., Activation of bone morphogenetic protein/Smad signaling in bronchial epithelial cells during airway inflammation. Am J Respir Cell Mol Biol 2002; 27: 160-169.
14. Marshall CJ, Kinnon C, Thrasher AJ,. Polarized expression of bone morphogenetic protein-4 in the human aorta-gonad-mesonephros region. Blood 2000; 96: 1591-1593.
15. Kotake Y, Nakagawa T, Kitagawa K, et al., Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 2011; 30: 1956-1962.
16. Khaitan D, Dinger ME, Mazar J, et al., The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res 2011; 71: 3852-3862.
17. Gupta RA, Shah N, Wang KC, et al., Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-1076.
18. Carninci P, Kasukawa T, Katayama S, et al., The transcriptional landscape of the mammalian genome. Science 2005; 309: 1559-1563.
19. Yuan JH, Yang F, Wang F, et al., A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 2014; 25: 666-681.
20. Trimarchi T, Bilal E, Ntziachristos P, et al., Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia. Cell 2014; 158: 593-606.
21. Maass PG, Rump A, Schulz H, et al., A misplaced lncRNA causes brachydactyly in humans. J Clin Invest 2012; 122: 3990-4002.
22. Orom UA, Derrien T, Beringer M, et al., Long noncoding RNAs with enhancer-like function in human cells. Cell 2010; 143: 46-58.
23. Benetatos L, Vartholomatos G, Hatzimichael E,. MEG3 imprinted gene contribution in tumorigenesis. Int J Cancer 2011; 129: 773-779.
24. Zhou Y, Zhang X, Klibanski A,. MEG3 noncoding RNA: A tumor suppressor. J Mol Endocrinol 2012; 48: R45-53.
25. Li B, Fu J, Chen P, et al., Impairment in immunomodulatory function of mesenchymal stem cells from multiple myeloma patients. Arch Med Res 2010; 41: 623-633.
26. Le Blanc K, Fibbe W,. A new cell therapy registry coordinated by the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2008; 41: 319.
27. Giuliani N, Lisignoli G, Magnani M, et al., New insights into osteogenic and chondrogenic differentiation of human bone marrow mesenchymal stem cells and their potential clinical applications for bone regeneration in pediatric orthopaedics. Stem Cells Int 2013; 2013: 312501.
28. Pochampally RR, Smith JR, Ylostalo J, et al., Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Blood 2004; 103: 1647-1652.
29. Felka T, Schafer R, Schewe B, et al., Hypoxia reduces the inhibitory effect of IL-1beta on chondrogenic differentiation of FCS-free expanded MSC. Osteoarthritis Cartilage 2009; 17: 1368-1376.
30. Felka T, Schafer R, De Zwart P, et al., Animal serum-free expansion and differentiation of human mesenchymal stromal cells. Cytotherapy 2010; 12: 143-153.
31. Cordonnier T, Langonne A, Sohier J, et al., Consistent osteoblastic differentiation of human mesenchymal stem cells with bone morphogenetic protein 4 and low serum. Tissue Eng Part C, Methods 2011; 17: 249-259.
32. Zhuang W, Li B, Long L, et al., Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity. Int J Cancer 2011; 129: 2720-2731.
33. Goldring MB, Tsuchimochi K, Ijiri K,. The control of chondrogenesis. J Cell Biochem 2006; 97: 33-44.
34. Bandyopadhyay A, Tsuji K, Cox K, et al., Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet 2006; 2: e216.
35. Fang WT, Fan CC, Li SM, et al., Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma. Int J Cancer 2014; 135: 809-819.
36. Minguell JJ, Erices A, Conget P,. Mesenchymal stem cells. Exp Biol Med (Maywood) 2001; 226: 507-520.
37. Pittenger MF, Mackay AM, Beck SC, et al., Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
38. Zhang X, Gejman R, Mahta A, et al., Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 2010; 70: 2350-2358.
39. Jia LF, Wei SB, Gan YH, et al., Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. Int J Cancer 2014; 135: 2282-2293.
40. Bakrania P, Efthymiou M, Klein JC, et al., Mutations in BMP4 cause eye, brain, and digit developmental anomalies: Overlap between the BMP4 and hedgehog signaling pathways. Am J Hum Genet 2008; 82: 304-319.
41. Hung T, Chang HY,. Long noncoding RNA in genome regulation: Prospects and mechanisms. RNA Biol 2010; 7: 582-585.
42. Ma H, Hao Y, Dong X, et al., Molecular mechanisms and function prediction of long noncoding RNA. The Sci World J 2012; 2012: 541786.
43. Feng J, Bi C, Clark BS, et al., The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev 2006; 20: 1470-1484.
44. Cassiday LA, Maher LJ, 3rd. Having it both ways: Transcription factors that bind DNA and RNA. Nucleic Acids Res 2002; 30: 4118-4126.
45. Martianov I, Ramadass A, Serra Barros A, et al., Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 2007; 445: 666-670.
46. Rosenfeld MG, Lunyak VV, Glass CK,. Sensors and signals: A coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 2006; 20: 1405-1428.